Day, Gregory S http://orcid.org/0000-0001-5133-5538
Funding for this research was provided by:
National Institute on Aging (K23AG064029)
Article History
Received: 28 August 2021
Accepted: 10 September 2021
First Online: 23 September 2021
Declarations
:
: Not applicable.
: Not applicable.
: He owns stock (>$10,000) in ANI Pharmaceuticals (a generic pharmaceutical company). He serves as a topic editor for DynaMed (EBSCO), overseeing development of evidence-based educational content, a consultant for Parabon Nanolabs (advice relevant to NIH small business grant submission), and as the Clinical Director of the Anti-NMDA Receptor Encephalitis Foundation, Inc, Canada (uncompensated).